Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market dynamics of blood glucose monitoring have witnessed significant evolution over the years, driven by the increasing prevalence of diabetes and the growing emphasis on proactive healthcare management. As the number of individuals diagnosed with diabetes continues to rise globally, the demand for reliable and convenient blood glucose monitoring devices has surged. This market is characterized by a diverse range of products, including traditional glucometers, continuous glucose monitoring (CGM) systems, and non-invasive glucose monitoring technologies.
One key driver of market growth is the rising awareness of diabetes management and the importance of regular blood glucose monitoring. Healthcare providers and patients alike are recognizing the significance of early detection and continuous monitoring to prevent complications associated with diabetes. This heightened awareness has led to an increased adoption of advanced monitoring technologies, such as CGM systems, which offer real-time glucose data and help individuals make informed decisions about their lifestyle and treatment.
Technological advancements play a pivotal role in shaping the market dynamics of blood glucose monitoring. Innovations such as miniaturized sensors, wireless connectivity, and integration with smartphones have improved the user experience and made monitoring more convenient. The shift towards non-invasive monitoring methods, which eliminate the need for fingerstick testing, is gaining traction, offering a more comfortable alternative for patients.
Regulatory landscape and reimbursement policies also contribute to the market dynamics. Stringent regulatory requirements ensure the safety and efficacy of blood glucose monitoring devices, shaping the competitive landscape by favoring companies with compliant and reliable products. Additionally, favorable reimbursement policies can drive market growth, as they encourage both healthcare providers and patients to invest in advanced monitoring technologies for better disease management.
Competitive dynamics in the blood glucose monitoring market are characterized by the presence of established players and the emergence of new entrants. Leading companies continually invest in research and development to introduce innovative products, enhance existing technologies, and expand their market share. Collaborations between healthcare organizations and technology companies are becoming increasingly common, fostering a synergistic approach to diabetes management through comprehensive solutions.
Global economic factors and healthcare infrastructure also influence the market dynamics. Developing economies with a rising diabetic population are witnessing increased market penetration as awareness and affordability improve. The integration of blood glucose monitoring into telehealth platforms is a notable trend, providing remote monitoring solutions and extending healthcare access to underserved populations.
Challenges in the blood glucose monitoring market include issues related to accuracy, device affordability, and user compliance. Despite advancements, ensuring the precision of glucose readings remains a concern, particularly in non-invasive monitoring methods. Affordability is crucial for widespread adoption, and efforts to make these technologies more cost-effective are ongoing. User compliance is another challenge, as some individuals may resist incorporating regular monitoring into their daily routines.
EMEA Blood Glucose Monitoring Market Highlights:
EMEA Blood Glucose Monitoring Market Overview
EMEA Blood Glucose Monitoring Market Size was valued at USD 7.62 Billion in 2023. The EMEA Blood Glucose Monitoring industry is projected to grow from USD 8.03 Billion in 2024 to USD 14.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.99% during the forecast period (2024 - 2032).
One of the main objectives of diabetes treatment is to keep blood glucose level within a specified target range. Blood glucose monitoring is a process, which helps to identify the blood glucose level and notify if glucose level of blood is exceeding the limit. Thus, it helps to understand the food intake, exercise, insulin, and blood glucose level. The blood glucose monitoring devices provide useful information to manage diabetes. It helps to track the progress of treatment goal as well as monitor the effect of diabetes meditation on blood sugar level and understand the effect of illness and stress on the blood sugar level.
The EMEA blood glucose monitoring market is growing rapidly owing to the increasing prevalence of diabetes, innovative technology for monitoring and diagnosis of diabetes, early detection of diabetes, and increasing demand for continuous glucose monitoring devices.
Various blood glucose monitoring devices are available in the Europe and the Middle East and African market, which is referred as blood glucose meter. These devices help to identify the blood glucose level at home, clinics, hospitals, etc. Furthermore, they are designed to apply to the different type of diabetes such as Type 1 and Type 2.
Increasing diabetic patient in the Europe has increased the blood glucose monitoring devices market. Different types of glucose monitoring devices are available in the market such as blood glucose meter, continuous glucose monitoring system, Lancets, glucose monitoring strips, and others. Self-monitoring devices are the oldest method for monitoring blood glucose level and are widely used in home, hospital, and clinics.
EMEA Blood Glucose Monitoring Market Segment Insights
EMEA Blood Glucose Monitoring Product Type Insights
On the basis of the product type, the EMEA blood glucose monitoring market is segmented into invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), flash glucose monitoring devices, and others.
Europe, the Middle East, and Africa Blood Glucose Monitoring Application Insights
On the basis of the application, EMEA blood glucose monitoring market is segmented into type 1 diabetes, type 2 diabetes, and others.
EMEA Blood Glucose Monitoring End User Insights
On the basis of the end user, EMEA blood glucose monitoring market is segmented into diagnostic centers, hospitals, clinics, research centers, and home care diagnostics.
Europe, the Middle East, and Africa Blood Glucose Monitoring Regional Insights
On the regional basis, Europe, Middle East, and Africa blood glucose monitoring market is segmented into two major regions Europe and the Middle East and Africa.
Europe blood glucose monitoring devices market is showing swift growth owing to the increasing diabetic and obese population, unhealthy food, lack of exercise, and many another factor. Europe is leading the market growth with 60% of market share of EMEA market. According to the WHO, in 2016, around 60 million people had diabetes, and its prevalence is increasing in all age groups in Europe.
The Middle East and Africa account for the least share of market owing to poor political conditions in Africa and limited availability of funds and availability of medical facilities but, sound growth is expected over the review period. The Middle East holds the major share of the Middle East & African market due to the presence of well-developed countries like Kuwait, Qatar, Oman and South Arabia. Whereas, African region is expecting a healthy growth due to the presence of a huge opportunity for the development of the market.
EMEA Blood Glucose Monitoring Market Key Players
Some of the key players in this market are:
- Abbott Laboratories (US)
- Arkay Inc. (Japan)
- Bayer Healthcare AG, (Germany)
- F.Hoffmann-La Roche (Switzerland)
- LifeScan
- Johnson & Johnson (U.S.)
- Medtronic plc.
- Nipro Diagnostics Inc.
- Terumo Medical Corporation
Intended Audience
- Blood Glucose Monitoring Devices Suppliers
- Blood Glucose Monitoring Devices Manufacturers
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
